150 related articles for article (PubMed ID: 19417160)
21. Proteomic profile regulated by the anticancer peptide CIGB-300 in non-small cell lung cancer (NSCLC) cells.
Rodríguez-Ulloa A; Ramos Y; Gil J; Perera Y; Castellanos-Serra L; García Y; Betancourt L; Besada V; González LJ; Fernández-de-Cossio J; Sanchez A; Serrano JM; Farina H; Alonso DF; Acevedo BE; Padrón G; Musacchio A; Perea SE
J Proteome Res; 2010 Oct; 9(10):5473-83. PubMed ID: 20804217
[TBL] [Abstract][Full Text] [Related]
22. Role of protein kinase CK2 phosphorylation in the molecular chaperone activity of nucleolar protein b23.
Szebeni A; Hingorani K; Negi S; Olson MO
J Biol Chem; 2003 Mar; 278(11):9107-15. PubMed ID: 12511551
[TBL] [Abstract][Full Text] [Related]
23. Targeting of Protein Kinase CK2 Elicits Antiviral Activity on Bovine Coronavirus Infection.
Ramón AC; Pérez GV; Caballero E; Rosales M; Aguilar D; Vázquez-Blomquist D; Ramos Y; Rodríguez-Ulloa A; Falcón V; Rodríguez-Moltó MP; Yang K; Perera Y; Perea SE
Viruses; 2022 Mar; 14(3):. PubMed ID: 35336959
[TBL] [Abstract][Full Text] [Related]
24. Targeting CK2 mediated signaling to impair/tackle SARS-CoV-2 infection: a computational biology approach.
Miranda J; Bringas R; Fernandez-de-Cossio J; Perera-Negrin Y
Mol Med; 2021 Dec; 27(1):161. PubMed ID: 34930105
[TBL] [Abstract][Full Text] [Related]
25. Specific interaction between casein kinase 2 and the nucleolar protein Nopp140.
Li D; Meier UT; Dobrowolska G; Krebs EG
J Biol Chem; 1997 Feb; 272(6):3773-9. PubMed ID: 9013635
[TBL] [Abstract][Full Text] [Related]
26. Phosphorylation-dependent migration of retinoblastoma protein into the nucleolus triggered by binding to nucleophosmin/B23.
Takemura M; Ohoka F; Perpelescu M; Ogawa M; Matsushita H; Takaba T; Akiyama T; Umekawa H; Furuichi Y; Cook PR; Yoshida S
Exp Cell Res; 2002 Jun; 276(2):233-41. PubMed ID: 12027453
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of cellular uptake, intracellular transportation, and degradation of CIGB-300, a Tat-conjugated peptide, in tumor cell lines.
Benavent Acero FR; Perera Negrin Y; Alonso DF; Perea SE; Gomez DE; Farina HG
Mol Pharm; 2014 Jun; 11(6):1798-807. PubMed ID: 24773585
[TBL] [Abstract][Full Text] [Related]
28. Requirement of the protein B23 for nucleolar disassembly induced by the FRGY2a family proteins.
Gonda K; Wudel J; Nelson D; Katoku-Kikyo N; Reed P; Tamada H; Kikyo N
J Biol Chem; 2006 Mar; 281(12):8153-60. PubMed ID: 16415342
[TBL] [Abstract][Full Text] [Related]
29. Molecular Pathways: Emergence of Protein Kinase CK2 (CSNK2) as a Potential Target to Inhibit Survival and DNA Damage Response and Repair Pathways in Cancer Cells.
Rabalski AJ; Gyenis L; Litchfield DW
Clin Cancer Res; 2016 Jun; 22(12):2840-7. PubMed ID: 27306791
[TBL] [Abstract][Full Text] [Related]
30. The synthetic peptide CIGB-300 modulates CK2-dependent signaling pathways affecting the survival and chemoresistance of non-small cell lung cancer cell lines.
Cirigliano SM; Díaz Bessone MI; Berardi DE; Flumian C; Bal de Kier Joffé ED; Perea SE; Farina HG; Todaro LB; Urtreger AJ
Cancer Cell Int; 2017; 17():42. PubMed ID: 28373828
[TBL] [Abstract][Full Text] [Related]
31. Gene expression profiling unveils the temporal dynamics of CIGB-300-regulated transcriptome in AML cell lines.
Vázquez-Blomquist D; Ramón AC; Rosales M; Pérez GV; Rosales A; Palenzuela D; Perera Y; Perea SE
BMC Genomics; 2023 Jul; 24(1):373. PubMed ID: 37400761
[TBL] [Abstract][Full Text] [Related]
32. Protein NPM3 interacts with the multifunctional nucleolar protein B23/nucleophosmin and inhibits ribosome biogenesis.
Huang N; Negi S; Szebeni A; Olson MO
J Biol Chem; 2005 Feb; 280(7):5496-502. PubMed ID: 15596447
[TBL] [Abstract][Full Text] [Related]
33. Compartmentation of the nucleolar processing proteins in the granular component is a CK2-driven process.
Louvet E; Junéra HR; Berthuy I; Hernandez-Verdun D
Mol Biol Cell; 2006 Jun; 17(6):2537-46. PubMed ID: 16540521
[TBL] [Abstract][Full Text] [Related]
34. CIGB-300 Anticancer Peptide Differentially Interacts with CK2 Subunits and Regulates Specific Signaling Mediators in a Highly Sensitive Large Cell Lung Carcinoma Cell Model.
Pérez GV; Rosales M; Ramón AC; Rodríguez-Ulloa A; Besada V; González LJ; Aguilar D; Vázquez-Blomquist D; Falcón V; Caballero E; Carvalho PC; Caldeira RS; Yang K; Perera Y; Perea SE
Biomedicines; 2022 Dec; 11(1):. PubMed ID: 36672551
[TBL] [Abstract][Full Text] [Related]
35. Optimizing CIGB-300 intralesional delivery in locally advanced cervical cancer.
Sarduy MR; García I; Coca MA; Perera A; Torres LA; Valenzuela CM; Baladrón I; Solares M; Reyes V; Hernández I; Perera Y; Martínez YM; Molina L; González YM; Ancízar JA; Prats A; González L; Casacó CA; Acevedo BE; López-Saura PA; Alonso DF; Gómez R; Perea-Rodríguez SE;
Br J Cancer; 2015 May; 112(10):1636-43. PubMed ID: 25880012
[TBL] [Abstract][Full Text] [Related]
36. Safety and preliminary efficacy data of a novel casein kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies.
Solares AM; Santana A; Baladrón I; Valenzuela C; González CA; Díaz A; Castillo D; Ramos T; Gómez R; Alonso DF; Herrera L; Sigman H; Perea SE; Acevedo BE; López-Saura P
BMC Cancer; 2009 May; 9():146. PubMed ID: 19439079
[TBL] [Abstract][Full Text] [Related]
37. Chimeric peptides as modulators of CK2-dependent signaling: Mechanism of action and off-target effects.
Zanin S; Sandre M; Cozza G; Ottaviani D; Marin O; Pinna LA; Ruzzene M
Biochim Biophys Acta; 2015 Oct; 1854(10 Pt B):1694-707. PubMed ID: 25936516
[TBL] [Abstract][Full Text] [Related]
38. Targeting chronic lymphocytic leukemia using CIGB-300, a clinical-stage CK2-specific cell-permeable peptide inhibitor.
Martins LR; Perera Y; Lúcio P; Silva MG; Perea SE; Barata JT
Oncotarget; 2014 Jan; 5(1):258-63. PubMed ID: 24473900
[TBL] [Abstract][Full Text] [Related]
39. The RNA binding activity of a ribosome biogenesis factor, nucleophosmin/B23, is modulated by phosphorylation with a cell cycle-dependent kinase and by association with its subtype.
Okuwaki M; Tsujimoto M; Nagata K
Mol Biol Cell; 2002 Jun; 13(6):2016-30. PubMed ID: 12058066
[TBL] [Abstract][Full Text] [Related]
40. Characterization and cellular localization of nucleophosmin/B23 in HeLa cells treated with selected cytotoxic agents (studies of B23-translocation mechanism).
Chan PK
Exp Cell Res; 1992 Nov; 203(1):174-81. PubMed ID: 1426041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
